Feasibility of Screening, Brief Intervention, Referral to Treatment With Peer Navigation (SBIRT-PN) for Underserved HIV+ Adults 50+ in Primary Care Settings.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Substance Use
- Sponsor
- Florida State University
- Enrollment
- 86
- Locations
- 3
- Primary Endpoint
- Number of Participants Ranking Intervention as Acceptable
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Substance misuse is a common problem among HIV+ individuals. Research suggests that a Screening, Brief Intervention, and Treatment (SBIRT) model can be effective in reducing substance misuse in the general older adult population; however these findings have not been verified in the more vulnerable HIV+ older adult population. The present study seeks to address the problem of substance misuse in older HIV+ adults by piloting a SBIRT model for older HIV+ adults in a in a primary care setting. Individual reductions in alcohol and drug use can have significant effects on public health and safety when observed over a large population at risk for substance use problems. With wider dissemination statewide, a relatively low-cost intervention such as SBIRT could offer demonstrated benefits in this population.
Detailed Description
The current project will pilot SBIRT with a peer navigator (SBIRT-PN) versus treatment at usual (TAU) to increase substance use treatment engagement among HIV-positive adults aged 50 years and older. The investigators will recruit patients from the Southern HIV and Alcohol Research Consortium (SHARC) HIV primary care clinic network. In order to develop effective substance use intervention models for HIV care settings the specific aims of the current project are: Aim1: Examine the feasibility of the SBIRT-PN model at the UF Health Infectious Disease-Medical Specialties Clinic. The investigators hypothesize that the SBIRT-PN model will demonstrate high feasibility within the UF Health Infectious Disease - Medical Specialties Clinic. Aim2a: Assess the acceptability of SBIRT-PN. The investigators hypothesize that SBIRT-PN will demonstrate high acceptability among patients enrolled in this condition. Aim2b: Assess the acceptability of SBIRT-PN among HIV-positive individuals by age cohort (younger vs older). The investigators hypothesize that SBIRT-PN will demonstrate higher acceptability among older HIV-positive patients enrolled in this condition. Aim3: Assess influence of SBIRT-PN model on treatment engagement and substance use compared to enhanced treatment as usual (TAU).The investigators hypothesize that those in the SBIRT-PN condition will evidence greater treatment engagement and a reduction in substance use.
Investigators
Nicole Ennis
Associate Professor
Florida State University
Eligibility Criteria
Inclusion Criteria
- •Receiving care at an Infectious disease Medical Clinic
- •HIV-positive (seropositive confirmed by medical records)
- •have a substance misuse screening score indicating moderate or high risk.
Exclusion Criteria
- •lack fluency in English
- •are unwilling to provide information for follow-up
- •plan to leave the area within 6 months
- •already have a referral to treatment from another provider
- •unable to provide informed consent due to cognitive impairment.
Outcomes
Primary Outcomes
Number of Participants Ranking Intervention as Acceptable
Time Frame: 30 Days
To examine ratings of acceptability, the investigators will use the overall acceptability score and percentage of acceptability. Overall acceptability will be assessed by summing ratings from the 10-item questionnaire to provide a total intervention acceptability score for the intervention, such that acceptability scores for the intervention could range from 10 (low acceptability) to 50 (high acceptability). The intervention will be considered to have acceptability if 80% of the participants rank the intervention as acceptable (i.e., 4 or higher) on 80% or more of the scale items. The investigators will then examine each question of the Acceptability Questionnaire separately to determine strengths and weaknesses of the intervention.
Secondary Outcomes
- Number of Participants Who Used Different Types of Substances (Self-Reported)(6 Months)
- Number of Participants Who Obtained Formal Substance Use Treatment(6 Months)
- Number of Participants Who Used Different Types of Substances (Biologically Confirmed Via Urinalysis)(6 Months)